People on the move … Feb. 17Important personnel changes you should know this week about the Association for Accessible Medicines, Maesa and more. There are some tough-love lessons to be learned from the events of the past yearAn aging population combined with increasing numbers of people diagnosed with chronic diseases are among the top factors set to influence innovation in the generics drug market in 2023. Retail sales rebound in January Retail sales in January were up 1.5% from December and increased 4.8% year-over-year, according to the National Retail Federation. Ahold Delhaize’s efforts to provide low prices impacts Q4 The retail conglomerate reported that group net sales increased by 8.1% at constant exchange rates and up 15.9% at actual exchange rates. Walmart to reportedly close 3 technology hubs Walmart is reportedly shutting down three of its U.S. technology hubs, requiring hundreds of workers to relocate to keep their jobs. In-stores sales on the rise despite inflation concerns U.S. retail sales rose 8.8% year-over-year in January, according to Mastercard SpendingPulse. Teva to pay Florida $6.73M to settle state’s price fixing claims Teva will pay Florida $6.73 million, and the state will dismiss all of its claims against the company and its affiliates once payment has been made. People on the move … Feb. 10 Important personnel changes you should know this week about Walmart, The Pharmaceutical Research and Manufacturers of America and more. Medly sells pharmacy assets to Walgreens for $19.35M Two months after filing for Chapter 11 bankruptcy protection, Brooklyn, N.Y.-based Medly Pharmacy is selling its pharmacy assets to Walgreens for $19.35 million. Aurobindo receives FDA nod for generic Pennsaid Diclofenac sodium topical solution is indicated for the treatment of osteoarthritis. First Previous 85 86 87 88 89 Next Last
